Citadel Advisors
GEHC icon

Citadel Advisors’s GE HealthCare GEHC Stock Holding History

Citadel Advisors’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.1M Buy
971,300
+474,000
+95% +$37.4M 0.01% 1092
2025
Q4 		$40.8M Sell
497,300
-108,400
-18% -$8.45M 0.01% 1602
2025
Q3 		$45.5M Sell
605,700
-83,700
-12% -$6.24M 0.01% 1482
2025
Q2 		$51.1M Sell
689,400
-345,700
-33% -$24.1M 0.01% 1229
2025
Q1 		$83.5M Buy
1,035,100
+514,378
+99% +$44.2M 0.02% 807
2024
Q4 		$40.7M Sell
520,722
-429,095
-45% -$36.5M 0.01% 1459
2024
Q3 		$89.1M Buy
949,817
+110,968
+13% +$9.31M 0.02% 766
2024
Q2 		$65.4M Buy
838,849
+208,017
+33% +$17M 0.01% 944
2024
Q1 		$57.3M Buy
630,832
+128,073
+25% +$10.7M 0.01% 1101
2023
Q4 		$38.9M Sell
502,759
-337,757
-40% -$23.7M 0.01% 1378
2023
Q3 		$57.2M Buy
840,516
+346,008
+70% +$25.2M 0.01% 969
2023
Q2 		$40.2M Buy
494,508
+5,819
+1% +$464K 0.01% 1226
2023
Q1 		$40.1M Buy
+488,689
New +$34.9M 0.01% 1265

Other funds holding GEHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Citadel Advisors's GEHC Position: Q1 2026 in Review

Citadel Advisors increased its GE HealthCare (GEHC) stake by 244% in Q1 2026, buying an estimated $72.3M and bringing the position to 1,293,268 shares worth $92.1M. The position accounts for 0.01% of the portfolio, ranked #871.

Citadel Advisors first reported a position in GEHC in Q4 2022 and has held it in 14 quarters since. The position peaked at $689M in Q2 2025. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Citadel Advisors held 1,293,268 shares of GE HealthCare worth $92.1M as of Q1 2026.
  • Citadel Advisors bought 917,266 GE HealthCare shares in Q1 2026, an estimated $72.3M.
  • GE HealthCare made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #871 holding.
  • Citadel Advisors first reported a position in GE HealthCare in Q4 2022 and has held it in 14 quarters since.
  • Citadel Advisors's GE HealthCare position peaked at $689M in Q2 2025.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.